Cetaphil® Moisturizing Cream as Inactive Control

DRUG2 trials

Sponsors

Galderma R&D, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions

Breast CancerMelasmaRadiation DermatitisSkin Microbiome

Phase 3

Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer

RecruitingNCT07066280

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityBreast Cancer, Radiation Dermatitis, Skin Microbiome

Start: 2025-04-10End: 2026-06-30Target: 326Updated: 2025-07-15

Phase 4

Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma

TerminatedNCT00669071

Galderma R&DMelasma

Start: 2008-01-31End: 2008-10-31Updated: 2022-08-23